CLOSE
SITE MAP
イノベーションが
生まれる「まち」。

2019/01/10

International Pitch 3 :Biobot Analytics: We analyze city sewage to measure population health

【300ピクセル】I-3 biobot analytics.png

【300ピクセル】biobot.jpgNoriko Endo

Spatial Epidemiologist, Biobot Analytics

[Summary]

Human health is reflected in urine, as it contains information on human metabolism, diet, drug consumption, and the presence of infectious viruses and bacteria. This rich source of information is flushed down the toilet every day and is aggregated in city sewage. Biobot Analytics mines this untapped human health information to advance health in cities.


Biobot Analytics' unique solution enables to monitor public health indicators with high specificity both in space and time. The company's first product in the United States is the Opioid Consumption Monitoring Program. Drug overdose is the leading cause of death for Americans under the age of 50. A panel of opioid metabolites is measured spatially and longitudinally, so that (1) consumption of different types of Opioids is quantified, (2) areas of high risk overdose death are identified, (3) temporal change in the consumption pattern is monitored. Such detailed information on opioid consumption has never been available. It will aid cities in making proactive decisions, leading to effective interventions.

Biobot Analytics has raised a seed funding of $2.5 million for implementing the solution to cities.


[Profile]

Noriko Endo (Dr.) is Spatial Epidemiologist at Biobot Analytics. Before joining Biobot Analytics, she worked at the Massachusetts Department of Public Health and at the Massachusetts Institute of Technology (MIT). PhD and MS in Environmental Engineering at MIT (2017, 2014). BEng in Civil Engineering at the University of Tokyo (2011).